De novo designed tetrahedral nanoparticle T33_dn2 presenting BG505 SOSIP trimers
收藏NIAID Data Ecosystem2026-05-01 收录
数据链接：
官方服务：
资源简介：
De novo designed tetrahedral nanoparticle T33_dn2 presenting BG505 SOSIP trimers
应用场景：
创建时间：
2024-03-06
相关数据集
The founder virus HIV envelope was developed based on the consensus sequence of 1894 subtype C founder virus sequences. The protein has been used as an immunogen has as a SOSIP.664 trimer shows antigenically relevant epitopes and improved immunogenicity.. The subtype C Founder Virus HIV Envelope
This study includes the development and characterization of a putative immunogen that resembles the HIV-1 native spike, is antigenically relevant and is able to produce broadly neutralizing antibodies
NIAID Data Ecosystem70
Further Developments of New Immunogenic Peptide-based HIV Vaccines Targeting Dendritic Cells, 2013
HIV is a chronic infection that damages the immune system and eventually give immunodeficiency and disease. Today we have medications that slows the multiplication of the virus and turns the developme
DataCite Commons2023-02-28 更新30
Comparative Immunogenicity of HIV-1 Clade C Envelope Proteins for Prime/Boost Studies
BackgroundPrevious clinical efficacy trials failed to support the continued development of recombinant gp120 (rgp120) as a candidate HIV vaccine. However, the recent RV144 HIV vaccine trial in Thailan
NIAID Data Ecosystem20
Vaccine-elicited NHP FP-targeting neutralizing antibody 0PV-b.01 in complex with HIV fusion peptide (residue 512-519)
Vaccine-elicited NHP FP-targeting neutralizing antibody 0PV-b.01 in complex with HIV fusion peptide (residue 512-519)
NIAID Data Ecosystem40
Summary of vaccine regimens.
# QS-21 & 3D-MPL in o/w emulsion.*A: 92UG037 B: 92US715 Bal: Ba-L C:96ZM651 E: 93TH976.
Figshare2015-12-02 更新30
